Treatment of resistant chronic central serous chorioretinopathy via platelet-rich plasma with electromagnetic stimulation

To evaluate whether subtenon injection of platelet-rich plasma (PRP) with retinal electromagnetic stimulation (rEMS) is effective in therapy-resistant chronic central serous chorioretinopathy (CSCR). The study included 22 eyes with resistant chronic CSCR. Cases receiving micropulse laser or additional photodynamic therapy, subtenon PRP, and subtenon PRP + rEMS were classified as times 1, 2 and 3,…

Photoactivated platelet rich plasma (PRP) based patient-specific bio-ink for cartilage tissue engineering

In the treatment of cartilage damage, the use of platelet rich plasma (PRP) is a personal therapeutic aid resource. In this study, it was aimed to increase the clinical effectiveness of this cocktail, which consists of growth factors necessary for wound healing and tissue regeneration. In this direction, photo-active and photo-crosslinkable bio-ink has been used…